Pretax income is the income that a company earns before paying income taxes. Novonesis (Novozymes) B's pretax income for the
three
months ended in Dec. 2024 was €327 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was €327 Mil.
Novonesis (Novozymes) B's pretax margin was 16.34%.
During the past 13 years, Novonesis (Novozymes) B's highest Pretax Margin was 27.44%. The lowest was 10.88%. And the median was 26.11%.
Novonesis (Novozymes) B Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Novonesis (Novozymes) B's Pre-Tax Income
For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novonesis (Novozymes) B's Pre-Tax Income Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Novonesis (Novozymes) B's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €327 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novonesis (Novozymes) B (FRA:NZM2) Pre-Tax Income Explanation
Novonesis (Novozymes) B's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 13 years, Novonesis (Novozymes) B's highest Pretax Margin was 27.44%. The lowest was 10.88%. And the median was 26.11%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Novonesis (Novozymes) B Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:NZM2 has been successfully added to your 